Biochemical studies of vascular endothelial growth factor in patients with liver diseases /
Heba Mohamed Mohamed Shehata
Biochemical studies of vascular endothelial growth factor in patients with liver diseases / دراسات كيميائية حيوية لعامل النمو للخلايا المبطنة للأوعية الدموية فى مرضى الكبد Heba Mohamed Mohamed Shehata ; Supervised Abdelgawad Ali Fahmi , Mohamed Ali Eldesouky , Amal Mohamed Ahmed - Cairo : Heba Mohamed Mohamed Shehata , 2012 - 132P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry
Chronic infection with hepatitis C virus (HCV) is a well established risk factor for the development of hepatocellular carcinoma (HCC) and in many areas of the world is the predominant etiology for hepatocarcinogenesis . The prevalence of HCV infection varies throughout the world , the highest number of infections is reported in Egypt . HCV accounts for about 70% of cases with chronic hepatitis , 40% with cirrhosis , 60% with HCC and 15 - 30% of liver transplantation
Hepatitis C virus Hepatocellular carcinoma Ü - fetoprotein
Biochemical studies of vascular endothelial growth factor in patients with liver diseases / دراسات كيميائية حيوية لعامل النمو للخلايا المبطنة للأوعية الدموية فى مرضى الكبد Heba Mohamed Mohamed Shehata ; Supervised Abdelgawad Ali Fahmi , Mohamed Ali Eldesouky , Amal Mohamed Ahmed - Cairo : Heba Mohamed Mohamed Shehata , 2012 - 132P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry
Chronic infection with hepatitis C virus (HCV) is a well established risk factor for the development of hepatocellular carcinoma (HCC) and in many areas of the world is the predominant etiology for hepatocarcinogenesis . The prevalence of HCV infection varies throughout the world , the highest number of infections is reported in Egypt . HCV accounts for about 70% of cases with chronic hepatitis , 40% with cirrhosis , 60% with HCC and 15 - 30% of liver transplantation
Hepatitis C virus Hepatocellular carcinoma Ü - fetoprotein